Summary
Cencora, Inc. (formerly AmerisourceBergen Corporation) filed an 8-K on March 31, 2022, primarily detailing the approval of its 2022 Omnibus Incentive Plan by shareholders at the 2022 Annual Meeting. This new Equity Plan is designed to succeed the prior incentive plan and significantly increases the number of shares available for equity-based awards to employees, officers, directors, and consultants. The expansion of the share reserve, by an additional 22,750,000 shares, suggests a continued strategy of using equity compensation to attract, retain, and incentivize key personnel, which can be a positive signal for long-term value creation. The plan allows for various award types, including stock options, restricted stock units, and other equity-based instruments, with grants subject to the discretion of the Compensation and Succession Planning Committee. The Equity Plan will remain in effect for ten years, with no awards permitted after March 9, 2032. While the exact impact on individual compensation or share dilution is not yet quantifiable, the adoption of this plan underscores management's focus on aligning executive and employee interests with shareholder value.
Key Highlights
- 1Shareholders approved the AmerisourceBergen Corporation 2022 Omnibus Incentive Plan (Equity Plan) at the 2022 Annual Meeting.
- 2The Equity Plan replaces the AmerisourceBergen Corporation Omnibus Incentive Plan (Prior Plan).
- 3An additional 22,750,000 shares of common stock have been reserved for equity-based awards under the new plan.
- 4Awards can be granted to employees (including executive officers), consultants, independent contractors, and non-employee directors.
- 5The plan permits various award types such as stock options, stock appreciation rights, restricted stock units, and others.
- 6The Equity Plan is effective for ten years, with the last date for granting awards being March 9, 2032.
- 7The Compensation and Succession Planning Committee of the Board of Directors will determine the specifics of award grants.